Rheonix STI TriPlex Assay, Rheonix EncompassMDx Workstation (instrument and software), Rheonix Urine Specimen Collection Kit— 510(k) K193081

Substantially Equivalent

Rheonix, Inc.

FDA 510(k) clearance K193081 for Rheonix STI TriPlex Assay, Rheonix EncompassMDx Workstation (instrument and software), Rheonix Urine Specimen Collection Kit, Substantially Equivalent on 2021-12-17. Applicant: Rheonix, Inc..

Clearance details

Applicant
Rheonix, Inc.
Product code
Code QEP
Advisory panel
Microbiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Ithaca, NY, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.